Medshine discovery inc
Web10 apr. 2024 · Tnc fl/fl mouse line was purchase from Cyagen Biosciences Inc ... (MedShine, cat: 120503) for 6 consecutive days unless otherwise noted (62.5 mg for ... Discover content. Journals A-Z; Articles by ... Webmedshine discovery inc の過去 20年間 の特許出願件数推移(pct)を以下に示します。 特許件数推移は、特許分析において最も基本的な分析指標です。 特許件数推移を確認することで、企業・技術ごとの技術開発、研究開発への注力状況を確認できます。
Medshine discovery inc
Did you know?
Web12 jan. 2024 · Jan. 12, 2024 Jiangsu Chia Tai Tianqing Pharmaceutical Group Co. Ltd. and Medshine Discovery Inc. have identified benzoxazinone derivatives acting as … Web10 jan. 2024 · Medshine Discovery Inc. has identified proteolysis targeting chimeras (PROTACs) comprising cereblon (CRBN) ligands coupled to an androgen receptor …
http://db.idrblab.net/ttd/data/patent/details/t84726 Web12 apr. 2024 · Medshine Discovery Inc. has prepared octahydropyrazinodiazanaphthyridine dione compounds acting as GTPase KRAS inhibitors reported to be useful for the treatment of ...
Web4 dec. 2024 · BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY, MEDSHINE DISCOVERY INC. Inventors: Jiansong WANG, Zhengxia CHEN, Zhibo LUO, Meibi DAI, … WebDisclosed are a series of compounds having pyridine structures or pharmaceutically acceptable salts thereof, and an application thereof in the preparation of drugs for the treatment of related diseases. Specifically, disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
WebMEDSHINE DISCOVERY INC 100% similarity. ABBISKO THERAPEUTICS CO LTD 100% similarity. NHWA PHARMA CORP 100% similarity. CHAKRAVARTY SARVAJIT 100% similarity. Atrin Pharmaceuticals LLC 100% similarity. AGIOS PHARMACEUTICALS INC 99% similarity. IMPACT THERAPEUTICS INC 99% similarity.
Web7 aug. 2024 · Deep involvement of RAS proteins in cancer establishment made the discovery of RAS-targeted therapies being one of the most researched fields in the past … heartless act mtgWebMedshine Discovery Inc. has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant mount scopus st kildaWebHelicase-primase inhibitors from Medshine Discovery Inc. (WO2024/127207 and WO2024/007355) for the treatment of herpes simplex virus infections – structure … mount scopus national botanical gardenWeb19 aug. 2024 · We describe the opportunities and limitations of the helicase-primase inhibitor patent portfolio from Phaeno Therapeutics and propose the structure of their … mount scopus school holidays 2022Web8 apr. 2024 · Assignee: MEDSHINE DISCOVERY INC. Inventors: Kevin X Chen, Yanxin Yu, Xinde Chen, Li Zhang, Zhaoguo Chen, Cheng Xie, Xiaofei Wang, Linghui Wu, Guoping Hu, Jian Li, Shuhui Chen Quinazoline compound for EGFR inhibition Patent number: 11040984 Abstract: Disclosed is a novel quinazoline compound. heartless abdWeb16 mrt. 2024 · Medshine Discovery patents new LSD1 and HDAC1 dual inhibitors. Medshine Discovery Inc. has synthesized dual N - (2-aminophenyl)benzamide … mount scopus wikipediaWebXuzhou Medshine Technology Co.,Ltd (hereinafter referred to as MedShine), compounded with the R&D and sale of medical device, is a professional supplier of medical equipment … heartless album kanye